LLY vs. WMT: Eli Lilly vs. Walmart Stock Comparison
How do Eli Lilly (LLY) and Walmart (WMT) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Eli Lilly (LLY) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas Walmart (WMT) belongs to Consumer Staples (Consumer Staples Distribution & Retail) — their GICS classifications point to very different parts of the market.
| Profile Item | LLY | WMT |
|---|---|---|
| Name | Eli Lilly and Company | Walmart Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Consumer Staples |
| GICS Industry Group | Pharmaceuticals, Biotechnology & Life Sciences | Consumer Staples Distribution & Retail |
| GICS Industry | Pharmaceuticals | Consumer Staples Distribution & Retail |
| GICS Sub-Industry | Pharmaceuticals | Consumer Staples Merchandise Retail |
| Market Capitalization | 1,206.07 billion USD | 998.90 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | Nasdaq |
| Listing Date | June 1, 1972 | August 25, 1972 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | LLY | WMT |
|---|---|---|
| Total Return (1Y) | 52.36% | 23.19% |
| Total Return (3Y, Annualized) | 34.18% | 33.27% |
| Total Return (5Y, Annualized) | 41.08% | 21.72% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | LLY | WMT |
|---|---|---|
| Volatility (1Y, Annualized) | 35.34% | 26.96% |
| Beta (5Y) | 0.40 | 0.52 |
| Max Drawdown (5Y) | -34.48% | -25.74% |
| Avg. Volume (3M) | 2.52M | 23.66M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | LLY | WMT |
|---|---|---|
| Sharpe Ratio (1Y) | 1.36 | 0.70 |
| Sortino Ratio (1Y) | 2.29 | 1.00 |
Profitability
ROE (TTM)
Eli Lilly (LLY) at 86.02% sits in the top ROE quartile, while Walmart (WMT) at 22.31% is closer to the peer norm — stronger capital efficiency for LLY.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
86.02%
- Max
- 109.18%
- LLY
- 86.02%
- Q3
- 6.23%
- Median
- -26.66%
- Q1
- -64.05%
- Min
- -167.77%
WMT
Consumer Staples Distribution & Retail industry group
22.31%
- Max
- 33.48%
- WMT
- 22.31%
- Q3
- 22.31%
- Median
- 15.57%
- Q1
- 7.66%
- Min
- -2.27%
Net Margin (TTM)
Eli Lilly (LLY) at 31.90% converts revenue to bottom-line profit above its industry’s benchmark range, while Walmart (WMT) at 3.00% keeps roughly the typical share for its industry.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
31.90%
- LLY
- 31.90%
- Max
- 18.05%
- Q3
- 4.78%
- Median
- 0.00%
- Q1
- -4.14%
- Min
- -17.05%
WMT
Consumer Staples Distribution & Retail industry group
3.00%
- Max
- 5.45%
- Q3
- 3.42%
- WMT
- 3.00%
- Median
- 2.44%
- Q1
- 1.86%
- Min
- -0.06%
Operating Margin (TTM)
Eli Lilly (LLY) at 53.66% operates in the top operating margin quartile, ahead of Walmart (WMT) at 3.45%, which runs around its industry’s norm.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
53.66%
- Max
- 83.12%
- LLY
- 53.66%
- Q3
- 14.77%
- Median
- 0.00%
- Q1
- -78.82%
- Min
- -207.40%
WMT
Consumer Staples Distribution & Retail industry group
3.45%
- Max
- 6.81%
- Q3
- 5.49%
- Median
- 3.84%
- WMT
- 3.45%
- Q1
- 2.00%
- Min
- 0.97%
Profitability Metrics
| Metric | LLY | WMT |
|---|---|---|
| ROE (TTM) | 86.02% | 22.31% |
| ROA (TTM) | 21.06% | 6.41% |
| Net Margin (TTM) | 31.90% | 3.00% |
| Operating Margin (TTM) | 53.66% | 3.45% |
| Gross Margin (TTM) | 83.63% | 24.84% |
Growth
Revenue Growth
Both Eli Lilly (LLY) at 44.70% and Walmart (WMT) at 4.73% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Eli Lilly (LLY) at 95.99% sits in the top EPS growth quartile, while Walmart (WMT) at 13.28% is closer to the peer norm — faster per-share earnings growth for LLY.
Growth Metrics
| Metric | LLY | WMT |
|---|---|---|
| Revenue Growth (YoY) | 44.70% | 4.73% |
| Revenue Growth (3Y CAGR) | 31.69% | 5.27% |
| EPS Growth (YoY) | 95.99% | 13.28% |
| EPS Growth (3Y CAGR) | 51.71% | 24.25% |
Financial Strength
Current Ratio (MRQ)
Both Eli Lilly (LLY) at 1.39 and Walmart (WMT) at 0.77 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.39
- Max
- 25.13
- Q3
- 12.13
- Median
- 5.52
- Q1
- 2.47
- LLY
- 1.39
- Min
- 0.10
WMT
Consumer Staples Distribution & Retail industry group
0.77
- Max
- 2.04
- Q3
- 1.45
- Median
- 1.17
- Q1
- 1.00
- WMT
- 0.77
- Min
- 0.69
Debt / Equity (MRQ)
Walmart (WMT) at 0.72 carries an industry-typical debt-to-equity mix, while Eli Lilly (LLY) at 1.23 uses more debt funding than most peers.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.23
- Max
- 1.42
- LLY
- 1.23
- Q3
- 0.65
- Median
- 0.15
- Q1
- 0.02
- Min
- 0.00
WMT
Consumer Staples Distribution & Retail industry group
0.72
- Max
- 2.59
- Q3
- 1.83
- Median
- 1.24
- WMT
- 0.72
- Q1
- 0.63
- Min
- 0.01
Financial Strength Metrics
| Metric | LLY | WMT |
|---|---|---|
| Current Ratio (MRQ) | 1.39 | 0.77 |
| Debt / Equity (MRQ) | 1.23 | 0.72 |
| Net Debt / EBITDA | 0.96 | 1.44 |
Dividends
Dividend Yield (TTM)
Walmart (WMT) at 0.76% pays an industry-typical yield; Eli Lilly (LLY) at 0.49% is above its entire peer range — the higher number, but one that calls for a look at payout sustainability before treating it as an advantage.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
0.49%
- LLY
- 0.49%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
WMT
Consumer Staples Distribution & Retail industry group
0.76%
- Max
- 2.90%
- Q3
- 1.72%
- WMT
- 0.76%
- Median
- 0.43%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Both pay out more than their industries’ typical bands, and LLY more so: Walmart (WMT) at 34.96% sits above the band, while Eli Lilly (LLY) at 21.71% exceeds every peer in its group.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
21.71%
- LLY
- 21.71%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
WMT
Consumer Staples Distribution & Retail industry group
34.96%
- Max
- 57.98%
- WMT
- 34.96%
- Q3
- 30.05%
- Median
- 11.72%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | LLY | WMT |
|---|---|---|
| Dividend Yield (TTM) | 0.49% | 0.76% |
| Dividend Payout Ratio (TTM) | 21.71% | 34.96% |
Valuation
P/E Ratio (TTM)
Both Eli Lilly (LLY) at 43.95 and Walmart (WMT) at 45.48 sit in the richer earnings-multiple quartile for P/E ratio, so investors are paying more for TTM earnings than they pay for typical peers.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
43.95
- Max
- 85.34
- LLY
- 43.95
- Q3
- 43.46
- Median
- 26.69
- Q1
- 13.30
- Min
- 0.07
WMT
Consumer Staples Distribution & Retail industry group
45.48
- Max
- 50.75
- WMT
- 45.48
- Q3
- 33.64
- Median
- 22.19
- Q1
- 16.09
- Min
- 9.28
P/S Ratio (TTM)
Eli Lilly (LLY) at 13.95 is priced about in line with its industry on P/S ratio, while Walmart (WMT) at 1.36 sits in the pricier quartile — WMT costs more per dollar of sales.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
13.95
- Max
- 58.18
- Q3
- 25.77
- LLY
- 13.95
- Median
- 7.30
- Q1
- 3.01
- Min
- 0.01
WMT
Consumer Staples Distribution & Retail industry group
1.36
- Max
- 1.54
- WMT
- 1.36
- Q3
- 0.81
- Median
- 0.47
- Q1
- 0.26
- Min
- 0.02
P/B Ratio (MRQ)
Both look rich against book: Walmart (WMT) at 10.15 sits in the upper P/B ratio quartile, and Eli Lilly (LLY) at 29.96 prices even higher, above its industry range.
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
29.96
- LLY
- 29.96
- Max
- 13.53
- Q3
- 6.54
- Median
- 3.25
- Q1
- 1.69
- Min
- -5.59
WMT
Consumer Staples Distribution & Retail industry group
10.15
- WMT
- 10.15
- Max
- 10.15
- Q3
- 6.27
- Median
- 3.70
- Q1
- 1.85
- Min
- 0.93
Valuation Metrics
| Metric | LLY | WMT |
|---|---|---|
| P/E Ratio (TTM) | 43.95 | 45.48 |
| P/S Ratio (TTM) | 13.95 | 1.36 |
| P/B Ratio (MRQ) | 29.96 | 10.15 |
| Free Cash Flow Yield (TTM) | 0.77% | 0.71% |